📣 VC round data is live. Check it out!
- Public Comps
- Emvision
Emvision Valuation Multiples
Discover revenue and EBITDA valuation multiples for Emvision and similar public comparables like Edap TMS, Nyxoah, Onyx Healthcare, Vuno and more.
Emvision Overview
About Emvision
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury.
Founded
2017
HQ

Employees
N/A
Website
Financials (LTM)
EV
$119M
Valuation Multiples
Start free trialEmvision Financials
Emvision reported last 12-month revenue of $4M and negative EBITDA of ($6M).
In the same LTM period, Emvision generated ($6M) in EBITDA losses and had net loss of ($7M).
Revenue (LTM)
Emvision P&L
In the most recent fiscal year, Emvision reported revenue of — and net income of —.
Financial data powered by Morningstar, Inc.
Emvision Stock Performance
Emvision has current market cap of $129M, and enterprise value of $119M.
Market Cap Evolution
Emvision's stock price is $1.39.
Emvision share price increased by 9.5% in the last 30 days, and by 15.0% in the last year.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $119M | $129M | -0.3% | 9.5% | 9.8% | 15.0% | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEmvision Valuation Multiples
Emvision trades at 30.3x EV/Revenue multiple, and (19.7x) EV/EBITDA.
EV / Revenue (LTM)
Emvision Financial Valuation Multiples
As of May 7, 2026, Emvision has market cap of $129M and EV of $119M.
Emvision has a P/E ratio of (19.7x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Emvision Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Emvision Margins & Growth Rates
Emvision Margins
Emvision Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Emvision Operational KPIs
Emvision's Rule of 40 is (189%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Emvision's Rule of X is (190%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Emvision Competitors
Emvision competitors include Edap TMS, Nyxoah, Onyx Healthcare, Vuno, AVITA Medical, NN, SANUWAVE Health, Laxmi Dental, CROSSJECT and Paxman.
Most Emvision public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.9x | 1.9x | (5.5x) | (6.2x) | |||
| 10.3x | 5.9x | (1.4x) | (1.3x) | |||
| 3.1x | — | 27.2x | — | |||
| 4.9x | — | (45.9x) | — | |||
| 2.2x | 2.1x | (4.0x) | (4.7x) | |||
| 0.7x | 0.7x | 18.5x | 6.2x | |||
| 3.3x | 3.1x | 7.5x | 10.0x | |||
| 4.9x | 4.1x | 22.0x | 25.2x | |||
This data is available for Pro users. Sign up to see all Emvision competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Emvision
| When was Emvision founded? | Emvision was founded in 2017. |
| Where is Emvision headquartered? | Emvision is headquartered in Australia. |
| Is Emvision publicly listed? | Yes, Emvision is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Emvision? | Emvision trades under EMV ticker. |
| When did Emvision go public? | Emvision went public in 2018. |
| Who are competitors of Emvision? | Emvision main competitors include Edap TMS, Nyxoah, Onyx Healthcare, Vuno, AVITA Medical, NN, SANUWAVE Health, Laxmi Dental, CROSSJECT, Paxman. |
| What is the current market cap of Emvision? | Emvision's current market cap is $129M. |
| What is the current revenue of Emvision? | Emvision's last 12 months revenue is $4M. |
| What is the current revenue growth of Emvision? | Emvision revenue growth (NTM/LTM) is (7%). |
| What is the current EV/Revenue multiple of Emvision? | Current revenue multiple of Emvision is 30.3x. |
| Is Emvision profitable? | No, Emvision is not profitable. |
| What is the current EBITDA of Emvision? | Emvision has negative EBITDA and is not profitable. |
| What is Emvision's EBITDA margin? | Emvision's last 12 months EBITDA margin is (154%). |
| What is the current EV/EBITDA multiple of Emvision? | Current EBITDA multiple of Emvision is (19.7x). |
| What is the current FCF of Emvision? | Emvision's last 12 months FCF is ($6M). |
| What is Emvision's FCF margin? | Emvision's last 12 months FCF margin is (148%). |
| What is the current EV/FCF multiple of Emvision? | Current FCF multiple of Emvision is (20.5x). |
| How many companies Emvision has acquired to date? | Emvision hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Emvision has invested to date? | Emvision hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Emvision
Lists including Emvision
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.